What are the side effects of artesunate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 22, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Side Effects of Artesunate

Intravenous artesunate can cause post-artesunate delayed hemolysis (PADH) and hemoglobinuria as its most serious adverse effects. 1

Common Side Effects

Artesunate is generally well-tolerated compared to other antimalarial medications, but several side effects have been documented:

Mild to Moderate Side Effects

  • Nausea and vomiting 2
  • Diarrhea 3
  • Anorexia 2
  • Dizziness 2

Serious Side Effects

  • Post-artesunate delayed hemolysis (PADH) - A significant concern requiring monitoring on days 7,14,21, and 28 after treatment 1
  • Hemoglobinuria - Presence of blood in urine 1
  • Neutropenia - Abnormally low neutrophil count 4
  • Anemia - Can occur during or after treatment 4
  • Elevated liver enzymes - Indicating potential liver stress 4
  • Severe allergic reactions - Including rare cases of anaphylaxis 4

Side Effects Based on Administration Route

Intravenous Artesunate

  • Used for severe malaria (first-line treatment)
  • Dosage: 2.4 mg/kg IV at 0,12,24 hours, then daily until oral medication can be taken 5
  • Requires monitoring for PADH with hemoglobin, haptoglobin, and lactate dehydrogenase levels at days 7,14,21, and 28 1

Oral Artesunate

  • Better tolerated than IV formulation
  • Common side effects include mild nausea, vomiting, anorexia, and dizziness 2
  • When combined with mefloquine, side effects increase significantly 2

Special Populations

Pregnancy

  • Artesunate has shown embryotoxicity in animal studies with embryo loss and cardiovascular malformations at high doses 6
  • No-effect levels were in the range of 5-7 mg/kg/day in animal studies 6
  • Limited human data has not shown adverse developmental effects in pregnant women 6

Children

  • Generally well-tolerated in children
  • Dosing for severe malaria in children is the same as adults: 2.4 mg/kg IV at 0,12,24 hours, then daily 7

Monitoring Recommendations

For patients receiving IV artesunate for severe malaria:

  1. Monitor parasitemia every 12 hours until decline to <1%, then every 24 hours until negative 1
  2. Check complete blood count, liver function, kidney function, and metabolic parameters daily 1
  3. Specifically monitor for PADH on days 7,14,21, and 28 after treatment 1
  4. Parameters to check: hemoglobin, haptoglobin, and lactate dehydrogenase levels 1

Comparison with Other Antimalarials

Artesunate has fewer side effects compared to quinine, which can cause:

  • Cinchonism (tinnitus, vertigo, headache, acute hearing loss)
  • Hypoglycemia
  • QT prolongation 1

Clinical Pearls

  • Artesunate alone is well-tolerated, but side effects increase significantly when combined with other antimalarials like mefloquine 2
  • High-dose artesunate (10 mg/kg/day, at the upper limit of WHO recommendations) has been associated with increased gastrointestinal side effects 3
  • Anaphylactic reactions to artesunate are rare but have been reported 4
  • For uncomplicated malaria, oral artesunate is typically given as part of combination therapy to prevent resistance development 8

Related Questions

Can artesunate (injection) be given on the same day as artemether (injection)?
What are the recommended artesunate dosing regimens for severe and uncomplicated acute malaria in adults, children, and pregnant women, and what are the alternative parenteral treatments if artesunate is unavailable?
What is artesunate, including its active component, mechanism of action, approved and off‑label indications, dosage forms and dosing regimens, safety profile, pharmacokinetics, resistance mechanisms, clinical considerations, drug interactions, and contraindications?
When can oral antimalarials be started after completing intravenous (IV) artesunate?
What do NACO (National AIDS Control Organization), CDC (Centers for Disease Control and Prevention), WHO (World Health Organization), and NCBI (National Center for Biotechnology Information) guidelines say about the reliability of a non-reactive HIV test result at 62 days post-exposure?
What is the likelihood of HIV infection with non-reactive 4th generation ELISA (Enzyme-Linked Immunosorbent Assay) tests at 31, 41, and 62 days post-exposure and no Post-Exposure Prophylaxis (PEP) taken?
What is the recommended management for extensive groin cellulitis?
What is the recommended melatonin (melatonin) dosage for a 9-month-old infant?
What does a high EBV VCA Ab (IgG) and EBV EBNA Ab (IgG), low White Blood Cell count, and high C-Reactive Protein indicate for this patient?
What is the recommended initial dose of Syntocinon (oxytocin) for managing postpartum hemorrhage (PPH)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.